TerumoTERUMO CORPORATION4543東証プライム精密機器FY ending Mar 2026, consolidated, IFRS

Which Terumo businesses make the profit?

Revenue by business segment, and the profit each one keeps.

Revenue by geography

Geographic revenue reported in annual filings

No geographic revenue breakdown was disclosed.

※ Segment figures include inter-segment sales and do not sum to the company total

Revenue and profit mix

FY ending Mar 2026

Revenue mix

Profit mix (profitable segments)

Cardiac and Vascular Company accounts for 60% of revenue and 74% of profit.

  • Cardiac and Vascular Company
    Revenue 59.8%Profit 74.3%Difference +14.5 ptMargin 24.2%Medical Devices
  • Terumo Organ Technologies
    Revenue 0.7%Profit 0.8%Difference +0.0 ptMargin 20.9%Medical Devices
  • Blood and Cell Technologies Company
    Revenue 20.4%Profit 15.2%Difference -5.2 ptMargin 14.6%Medical Devices
  • Medical Care Solutions Company
    Revenue 19.1%Profit 9.8%Difference -9.3 ptMargin 10.0%Medical Devices

Calculated from disclosed figures; listed by margin. Difference = profit share − revenue share (percentage points). Segment revenues may include inter-segment sales and may not sum to company revenue.

Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.

Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.

Segment history (JPY millions)

SegmentRevenue CAGRFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cardiac and Vascular Company+15.5%5y397,13023.5%480,61023.3%555,71622.3%624,35724.8%676,42124.2%
Medical Care Solutions Company+4.2%5y185,33512.7%191,7497.7%197,56910.0%211,23510.9%216,13810.0%
Blood and Cell Technologies Company+16.1%5y120,58617.3%147,6057.6%168,3289.7%200,28013.2%231,03714.6%
Terumo Organ TechnologiesN/A————7,98520.9%

Top: revenue. Bottom: operating margin.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第111期(2025/04/01-2026/03/31)

    ID S100YGMG2026-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第110期(2024/04/01-2025/03/31)

    ID S100VWHX2025-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第109期(2023/04/01-2024/03/31)

    ID S100TULJ2024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第108期(2022/04/01-2023/03/31)

    ID S100R4TX2023-06-28Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第107期(令和3年4月1日-令和4年3月31日)

    ID S100OS1S2022-07-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第106期(令和2年4月1日-令和3年3月31日)

    ID S100LLAO2021-06-23Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.